J. Puolivali et al., MUSCARINIC M-1 AND M-2 RECEPTOR SUBTYPE-SELECTIVE DRUGS MODULATE NEOCORTICAL EEG VIA THALAMUS, NeuroReport, 9(8), 1998, pp. 1685-1689
THE present study was designed to investigate the effects of infusions
into reticular nucleus of thalamus (NRT) or intracerebroventricular (
i.c.v.) infusions of muscarinic M-1 and M-2 receptor subtype selective
drugs on thalamocortically generated neocortical high voltage spindle
s (HVSs) in awake immobile rats. NRT administration of 2.0 and 20.0 mu
g McN-A-343, a muscarinic M-1 agonist, and 20.0 mu g methoctramine, a
muscarinic M-2 antagonist, suppressed HVSs. The results suggest that
the blockade of presynaptic M-2 receptors and activation of post-synap
tic M(1 )receptors in the NRT suppress thalamocortical oscillations an
d increase neocortical electrical arousal. (C) 1998 Rapid Science Ltd.